We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Viral Protein Stops Inflammatory Response

By Biotechdaily staff writers
Posted on 02 Feb 2006
A viral protein has been found that inactivates the immune system's anti-inflammatory response mechanism, which shields the virus from immune attack but may be exploited as a drug to treat inflammatory diseases of the skin.

Investigators at the University of Illinois (Urbana-Champaign, USA) worked with the molluscum contagiosum virus (MCV), which causes a mild skin disease similar to chickenpox. More...
In particular they focused their attention on the product of the viral MC160 gene, which has a homologue in humans and in herpes viruses, that regulates the cellular transcription factor NF-kappaB. NF-kappaB is activated when cytokine tumor necrosis factor alpha (TNF-alpha) binds to its cognate, TNF receptor I.

Studies on the effect of the MC160 protein on T cells growing in culture showed that it significantly reduced TNF-alpha-mediated NF-kappaB activation. MC160 protein expression reduced IKK kinase activity and IKK subunit phosphorylation. This is a step common to multiple signal transduction pathways. These findings were published in the January 2006 issue of the Journal of Virology.

"Our findings regarding MC160 provide yet another example of how viruses inhibit NF-kappaB activation,” explained senior author Dr. Joanna L. Shisler, professor of microbiology at the University of Illinois. "So we are starting to get a broader feeling that there is a common mechanism, that of inhibiting NF-kappaB activity, that all viruses are trying to utilize to survive in the host. What is interesting is that MC160 appears to be doing it in a completely novel way, than any identified before, by focusing on this IKK complex. This virus makes other proteins that dampen the immune response, but MC160 seems to be an important one.”



Related Links:
University of Illinois

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.